Fundz

Biotia announces the approval of BIOTIA-ID, a genomic-based urine assay for infectious disease diagnoses, revolutionizing patient care.

Nov 04, 2024
New YorkBiotechnologyHealth CareArtificial IntelligenceHealth Diagnostics

Product Description

Biotia has gained regulatory approval for its BIOTIA-ID Urine NGS Assay, the first AI-powered genomic urine test approved by New York State. This milestone signifies Biotia’s dedication to high standards in diagnostic testing and aims to improve the detection of urinary tract infections.

Company Information

Company

Biotia

Location

New York, United States

About

Biotia is a health tech company located in New York, NY, that leverages sequencing-based technology and proprietary AI-powered software to rapidly and accurately identify microorganisms and antimicrobial resistance. Their mission is to fight infectious diseases by deploying the leading reference library of microbes worldwide. Biotia, a spinout company of Jacobs Technion-Cornell Institute at Cornell Tech, has a New York State CLIA lab for infectious disease diagnostics testing affiliated with SUNY Downstate Health Sciences University. Connect on Twitter | Facebook | LinkedIn

Fundz sees it the moment Biotia ships something new, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Biotia's next move

Learn about Strategic plan

Product Launch Insights

What this usually means
Market expansion signals
New product launches often coincide with market expansion initiatives

Biotia shipped something new. Fundz reads product launches, trademark filings and hiring together.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.